Spurwing

News

GLOBALHealthPR has boosted its Asia-Pacific reach with the addition of Spurwing Communications to its independent med comms network.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.